Novel spatial immune-based risk prediction platform can predict hepatocellular carcinoma recurrence
A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...
Pharmaceutical Technology on MSN4d
EC approves BMS’ Opdivo and Yervoy combo for HCC
The EC has approved BMS Opdivo in combination with Yervoy as a first-line treatment for adults with unresectable or advanced ...
Warrior Met Coal surges as Blue Creek boosts coal production capacity by 25%
Warrior Met Coal announces 25% increase in production capacity at its Blue Creek steelmaking coal project in Alabama.
Medscape9d
4 Factors Increase Variceal Bleeding Risk With Atezolizumab-Bevacizumab for HCC
Patients with advanced hepatocellular carcinoma (HCC) receiving atezolizumab-bevacizumab treatment were more likely to experience variceal bleeding if they had a low platelet count, main portal ...
pharmaphorum8d
Ipsen's Cabometyx recommended by NICE for previously treated HCC
Those adult patients who have had sorafenib as a treatment for HCC, a type of primary liver cancer – and who exhibit Child Pugh grade A liver impairment and an Eastern Cooperative Oncology Group ...